Willem Huisman

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats
    Willem Huisman
    Erasmus MC, Institute of Virology, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    J Gen Virol 85:1833-41. 2004
  2. ncbi Intrahost evolution of envelope glycoprotein and OrfA sequences after experimental infection of cats with a molecular clone and a biological isolate of feline immunodeficiency virus
    Willem Huisman
    Erasmus MC, Institute of Virology, Rotterdam, The Netherlands
    Virus Res 137:24-32. 2008
  3. ncbi Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA
    Willem Huisman
    Erasmus MC, Institute of Virology, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Vet Immunol Immunopathol 126:332-8. 2008
  4. ncbi Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in cats
    Willem Huisman
    Erasmus MC, Institute of Virology, Rotterdam, The Netherlands
    Vaccine 26:2553-61. 2008

Detail Information

Publications4

  1. ncbi Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats
    Willem Huisman
    Erasmus MC, Institute of Virology, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    J Gen Virol 85:1833-41. 2004
    ....
  2. ncbi Intrahost evolution of envelope glycoprotein and OrfA sequences after experimental infection of cats with a molecular clone and a biological isolate of feline immunodeficiency virus
    Willem Huisman
    Erasmus MC, Institute of Virology, Rotterdam, The Netherlands
    Virus Res 137:24-32. 2008
    ..Although the extent of variation was higher after infection with biological isolate AM19, a large portion of these variant sequences was already present in the inoculum...
  3. ncbi Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA
    Willem Huisman
    Erasmus MC, Institute of Virology, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Vet Immunol Immunopathol 126:332-8. 2008
    ..These recombinant viral vectors were used to immunize cats using a prime-boost regimen and the protective efficacy of this vaccination strategy was assessed after challenge infection of immunized cats with FIV...
  4. ncbi Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in cats
    Willem Huisman
    Erasmus MC, Institute of Virology, Rotterdam, The Netherlands
    Vaccine 26:2553-61. 2008
    ..Although the vaccines proved to be immunogenic, vaccinated cats were not protected from infection with FIV...